Clinical utility of targeted RNA sequencing in cancer molecular diagnostics

2025/07/17 by Robert Siddaway, Aida I. Glembocki, Aída Glembocki +23 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Glioma Diagnosis and Treatment #Mycobacterium research and diagnosis

paper · doi:10.1038/s41591-025-03848-8

crossref issued 2025/07/17 · crossref published 2025/07/17 · crossref published-online 2025/07/17 · openalex publication_date 2025/07/17 · crossref created 2025/07/17 · crossref published-print 2025/10/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/16 · crossref indexed 2026/07/06 · openalex updated_date 2026/07/23

Citations

• The mutational constraint spectrum quantified from variation in 141,456 humans
• Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples
• ComBat-seq: batch effect adjustment for RNA-seq count data

Discussions

• 🎉 We are excited to share our publication in Nature Medicine by Dr. Siddaway and colleagues, “Clinical utility of targeted RNA sequencing in cancer molecular diagnostics" 📊 doi.org/10.1038/s415... [bsky, 0 points, 0 comments]